Fresenius SE CEO To Quit After Earnings Outlook Sours

Fresenius SE said its long-serving Chief Executive Stephan Sturm would quit, to be replaced by the head of its drugs unit, after the diversified group's earnings were hit following the COVID pandemic and a surge in costs.


Editor's pick